Skip to main content
. 2023 Nov 7;30(11):9789–9812. doi: 10.3390/curroncol30110711

Table 5.

Small molecules in preclinical studies.

Small-Molecule Inhibitors in Preclinical Studies
Molecule Immune Checkpoint Pathways
SMI402 in tumor-bearing mice [91] TIM-3 Inhibition of tumor growth by increasing CD8+ T cell infiltration at tumor site
“Compounds 8 and 9” [92] B7-1, preventing interaction with CTLA-4 Lack of inhibition in a cell adhesion assay
Tubeimoside-1 (TBM-1) [89] PD-L1 Lysosomal degradation of PD-L1 in cancer cells via mTOR inactivation.